Rofecoxib
Top View
- 080901 the Coxibs, Selective Inhibitors of Cyclooxygenase-2
- VIOXX® (Rofecoxib Tablets and Oral Suspension)
- National PBM Drug Monograph Valdecoxib (Bextra®) VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel
- The Effect of Rofecoxib and Diclofenac on Blood Picture in Male Patients
- Network Pharmacology Approach to Decipher Signaling Pathways Associated with Target Proteins of Nsaids Against COVID‑19 Ki Kwang Oh, Md
- Appendix A. Pharmacokinetics, Indications and Dosing of Included Drugs
- Short Communication Synthesis and Anti
- Rofecoxib, As a Safe Alternative for Acetyl Salicylic Acid/Nonsteroidal Anti-Inflammatory Drug-Intolerant Patients S
- A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Rofecoxib, a Selective Cyclooxygenase-2 Inhibitor, On
- Cardiovascular Safety of Non-Steroidal Anti-Inflammatory Drugs: Network Meta-Analysis
- Voluntary Withdrawal of Rofecoxib (Vioxx)
- Decisional Summary
- Multiple Actions of Fenamates and Other Nonsteroidal Anti-Inflammatory Drugs on GABAA Receptors
- Non-Steroidal Anti-Inflammatory Drugs (Nsaids)
- COXIBS in Clinical Practice 2002 (Celecoxib, Rofecoxib, Consensus
- Non-Steroidal Antiinflammatory Drugs (Nsaids)
- The Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs: Putting the Evidence in Perspective
- Cox II Inhibitors Assessment Report